Market News

Eagle Asset Management Has Lowered Ss&C Technologies Holdings (SSNC) Holding; Valeritas Holdings (VLRX) Shorts Decreased By 5.26%

Eagle Asset Management Inc decreased Ss&C Technologies Holdings (SSNC) stake by 14.93% reported in 2017Q3 SEC filing. Eagle Asset Management Inc sold 8,866 shares as Ss&C Technologies Holdings (SSNC)’s stock rose 4.26%. The Eagle Asset Management Inc holds 50,505 shares with $2.03 million value, down from 59,371 last quarter. Ss&C Technologies Holdings now has $10.18 billion valuation. The stock decreased 1.73% or $0.87 during the last trading session, reaching $49.47. About 4.85M shares traded or 316.94% up from the average. SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) has risen 26.42% since January 13, 2017 and is uptrending. It has outperformed by 9.72% the S&P500.

Valeritas Holdings Incorporated (NASDAQ:VLRX) had a decrease of 5.26% in short interest. VLRX’s SI was 9,000 shares in January as released by FINRA. Its down 5.26% from 9,500 shares previously. With 174,700 avg volume, 0 days are for Valeritas Holdings Incorporated (NASDAQ:VLRX)’s short sellers to cover VLRX’s short positions. The SI to Valeritas Holdings Incorporated’s float is 1.24%. The stock increased 2.89% or $0.1 during the last trading session, reaching $3.56. About 18,679 shares traded. Valeritas Holdings, Inc. (NASDAQ:VLRX) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes. The company has market cap of $24.98 million. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy. It currently has negative earnings. The firm also develops h-Patch, a controlled delivery technology platform; Mini-Ject, a disposable needle-free injection system that delivers drugs ranging from small molecules to large proteins, as well as antibodies and vaccines; and Micro-Trans microneedle array patch technology to deliver drugs into the dermis layer of the skin.

Investors sentiment decreased to 1.34 in Q3 2017. Its down 0.71, from 2.05 in 2017Q2. It worsened, as 23 investors sold SSNC shares while 71 reduced holdings. 44 funds opened positions while 82 raised stakes. 172.27 million shares or 0.35% less from 172.87 million shares in 2017Q2 were reported. First Personal Finance Services reported 0% of its portfolio in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). 54,954 were reported by Great West Life Assurance Com Can. First Mercantile Tru holds 0.08% of its portfolio in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) for 11,127 shares. 259,239 are held by Fund Management. Peak6 Invs Ltd Partnership holds 0% or 6,909 shares in its portfolio. Northern Corp holds 976,204 shares. Koch Industries holds 0.09% in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) or 9,065 shares. Aperio Lc reported 23,805 shares. Florida-based Raymond James & Associates has invested 0% in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). Victory Mngmt has 0.11% invested in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) for 1.23 million shares. Tiaa Cref Inv Lc has invested 0.03% in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). Aqr Capital holds 0% in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) or 19,426 shares. Nomura Asset Mngmt Co Limited has 0.01% invested in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). Proshare Advsr Ltd Com holds 0% or 5,785 shares. Numeric Invsts Lc reported 0% of its portfolio in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC).

Eagle Asset Management Inc increased Macom Technology Solutions H (NASDAQ:MTSI) stake by 84,092 shares to 286,898 valued at $13.05 million in 2017Q3. It also upped Trico Bancshares (NASDAQ:TCBK) stake by 85,241 shares and now owns 279,929 shares. Lincoln Electric Holdings (NASDAQ:LECO) was raised too.

Among 13 analysts covering SS&C Techs (NASDAQ:SSNC), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. SS&C Techs had 34 analyst reports since July 27, 2015 according to SRatingsIntel. On Wednesday, July 5 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, October 26. The firm has “Buy” rating given on Monday, July 27 by Sandler O’Neill. Jefferies maintained it with “Buy” rating and $47.0 target in Friday, September 1 report. As per Sunday, October 8, the company rating was maintained by RBC Capital Markets. The firm earned “Outperform” rating on Tuesday, February 9 by Raymond James. As per Thursday, June 1, the company rating was maintained by Jefferies. The firm has “Hold” rating by Deutsche Bank given on Friday, July 14. The stock has “Buy” rating by Zacks on Wednesday, August 5. The company was initiated on Friday, May 13 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *